🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
cross sectional observational study, aimed to assess the electrophysiologic...
Status
Completed
Location
Kasr Alainy Teaching Hospital-Clinical Neurophysiology Unit
Start Date
2018-08-01
Trial ID
NCT04340999
Treatments Being Tested
Charcot Marie Tooth 1A (CMT 1A) is a common inherited disorder of the nerve...
Status
Completed
Location
University of Iowa
Start Date
2014-11-01
Trial ID
NCT02357355
Treatments Being Tested
The purpose for doing this study is to determine that whether use of Power ...
Status
Completed
Location
The University of Lahore
Start Date
2021-12-23
Trial ID
NCT05460026
Treatments Being Tested
In carpal tunnel syndrome,trigger points are often found in the biceps musc...
Status
Completed
Location
Guy Hains 2930 Côte RIchelieu
Start Date
2007-01
Trial ID
NCT00634738
Treatments Being Tested
Post-herpetic neuralgia (PHN) is the most frequent complications related to...
Status
Completed
Location
Pontificia Universidad Catolica de Chile
Start Date
2023-03-17
Trial ID
NCT06171243
Treatments Being Tested
A randomized, double-blind, placebo-controlled, multicenter, Phase II clini...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2024-12
Trial ID
NCT06722950
This is a phase 3 prospective randomised double-blind study versus placebo,...
Status
Completed
Location
Nantes University Hospital
Start Date
2021-12-16
Trial ID
NCT05000658
Treatments Being Tested
This work will answer two critical questions: 1) Does intensive interdiscip...
Status
Completed
Location
Boston Children's Hospital at Waltham
Start Date
2022-10-17
Trial ID
NCT05491499
This study is a Phase 3 extension, global, multicenter open-label study. Th...
Status
Enrolling By Invitation
Location
Alabama Neurology Associates- Site Number : 8400019
Start Date
2025-04-01
Trial ID
NCT06859099
Treatments Being Tested